Pharmarise Holdings Corporation
2796・Standard Market・Retail Trade
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 9 members in total, including 3 outside directors (outside ratio approximately 33%). The "Nomination and Compensation Committee" (established in May 2016, with outside officers holding a majority) deliberates on director nominations and compensation allocation. The Board of Corporate Auditors comprises 3 members (2 of whom are outside auditors) and coordinates with the internal audit and control office and the accounting auditor.
Risk Management
Positioning "dispensing errors" and "personal information protection" specific to dispensing pharmacies as the most critical risks, the company has established a multi-layered committee structure including the Dispensing Error Prevention Study Group, Error Prevention Committee, Dispensing Error Assessment Committee, and Personal Information Protection Committee. It has also set up a Compliance Committee and a Sustainability Committee, with a framework in place whereby the Sustainability Committee identifies sustainability risks, including climate change, and reports and resolves them at the Board of Directors.
Shareholder Returns
The basic policy is to pay a year-end dividend once annually. The actual result for FY2026 (ending May 2026) is ¥14 per share (total dividends of ¥161 million, payout ratio of 139.8%). The same amount of ¥14 is planned for FY2027 (ending May 2027) as well. Share buybacks can be flexibly implemented based on provisions in the Articles of Incorporation.
Dividend Policy
The amount of profit distribution is determined by comprehensively considering business performance and the payout ratio, with the basic policy of paying a year-end dividend once annually. Internal reserves are allocated to new store openings, business development, and strengthening the financial base. The actual result for FY2026 (ending May 2026) is ¥14 per share (total dividends of ¥161 million, payout ratio of 139.8%). The actual result for FY2025 (ending May 2025) is ¥14 per share (total dividends of ¥159 million). The forecast for FY2027 (ending May 2027) is ¥14 per share (forecast payout ratio of 1,408.9%).
ESG
Endorsed the TCFD recommendations and identified/disclosed 5 materiality themes, 21 issues, and KPIs (December 2024). GHG emissions (Scope 1+2) totaled 6,780 t-CO2e in FY2024 actuals, with targets of a 30% reduction by 2030 (versus FY2022) and carbon neutrality by 2050. In human capital, the company disclosed a 25.0% ratio of female managers (target: 30%) and a 72.7% rate of male employees taking childcare leave (exceeding the 50% target), while promoting human capital development initiatives such as next-generation leader training and the 1-on-1 project.
Last updated: August 25, 2025